Company / Depreciation & Amortization
Cardiff Oncology, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$364.0K
FY2025
5-year range
$236.0K / $466.0K
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $234,813 in FY2016 to $1M in FY2018.
Based on SEC 10-K filings.
$364,000 in FY2025 with a 5-year CAGR of -4.8%.
Increased from $236,000 to $364,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.8%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 8.5% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $364.0K | -8.5% |
| FY2024 | $398.0K | +68.6% |
| FY2023 | $236.0K | -47.7% |
| FY2022 | $451.0K | -3.2% |
| FY2021 | $466.0K | +0.0% |
| FY2020 | $466.0K | -5.7% |
| FY2019 | $494.2K | -60.4% |
| FY2018 | $1.2M | +16.6% |
| FY2017 | $1.1M | +355.5% |
| FY2016 | $234.8K | -38.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026